ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Anti-cancer targets and molecular mechanisms of formononetin in treating osteosarcoma based on network pharmacology

Chen, Lizhi; Zhou, Yue; Weng, Zheng; Liu, Shuang; Li, Ting; Wang, Yanfang; Yang, Yang; Liu, Hongmei*; Huang, Wenhua*南方医科大学
Aging-US2023-10-31
9阅读
引用收藏
分享

摘要

Osteosarcoma (OS) is a multifactorial bone malignancy that accounts for most cancers in children and adolescents. Formononetin has been proven to exhibit various pharmacological effects including anti-tumor, anti-obesity, anti-inflammation, and neuroprotective effects. Few studies have examined the pharmacological activities of formononetin in OS treatment, but the mechanism has not yet been completely elucidated. Network pharmacology is a new method based on the theory of system biology for analyzing the network of biological systems and selecting specific signal nodes for multi-target drug molecular design. Here, we used network pharmacology to explore the possible mechanism of formononetin in OS treatment. Human OS cell line MG63 was processed with four concentrations (0, 2, 5, 8 mu g/mL) of formononetin. Subsequently, an MTT assay was performed to test cell proliferation and a scratch test was used to evaluate the migration ability of cancer cells. Caspase-3, p53, p21, and bcl-2 expression levels incubated with different concentrations of formononetin in MG63 cells were determined using Western blotting. After treated with formononetin for 48 h, MG63 cells exhibited marked apoptosis. The results revealed that certain concentrations of formononetin significantly exerted inhibitory effects on MG63 cell proliferation. Furthermore, formononetin decreased the bcl-2 level in MG63 cells but increased caspase-3, p21, and p53 levels in a concentration-dependent manner. Additionally, formononetin suppressed the expression of SATB2. Therefore, formononetin could dosedependently inhibit MG63 cell proliferation and induce apparent cell apoptosis, providing a candidate treatment for OS, whereas SATB2 could be a potential prognostic biomarker for screening OS and therapeutic target of formononetin.

学科与关键词

关键词
formononetinosteosarcomanetwork pharmacology
相关
加载中…
  • Network pharmacology and experimental verification-based strategy for exploring the mechanisms of luteolin in the treatment of osteosarcoma
    Huang, Renxuan; Xu, Mingxian; Guo, Weitang; Cheng, Mingzhe; Dong, Rui; Tu, Jian; Xu, Shao*; Zou, Changye*Cancer Cell International, 2023, 23(1): 213.被引 1
  • Network Pharmacology Prediction: The Possible Mechanisms of Cinobufotalin against Osteosarcoma
    Chen, Riyu; Guan, Zeyi; Zhong, Xianxing; Zhang, Wenzheng*; Zhang, Ya*Computational and Mathematical Methods in Medicine, 2022, 2022: 3197402.被引 6
  • Comparative transcriptomic analysis and mechanistic characterization revealed the use of formononetin for bladder cancer treatment
    Zhou, Huanhuan; Wang, Ping; Qin, Xian; Zhang, Xing*; Lai, Keng Po*; Chen, Jian*Food & Function, 2023, 14(12): 5787-5804.
查看全部 →

发表信息

论文状态
公开发表
期刊
Aging-US
发表日期
2023-10-31
卷期
第 15 卷, 第 20 期
页码
11489-11507
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82204791]; Science and Technology Projects in Guangzhou [202201020241, 202201011281]; Natural Science Foundation of Guangdong Province [2020A1515010002]; Doctoral workstation foundation of Guangdong Second Provincial General hospital [2020BSGZ049]; Science foundation of Guangdong Second Provincial General hospital [3D-A2021004]

作者

  • C

    Chen, Lizhi (第一作者)

    southern med univ

  • Z

    Zhou, Yue

查看全部 9 位作者收起作者
  • W

    Weng, Zheng

    2

  • L

    Liu, Shuang

  • L

    Li, Ting

    southern med univ

  • W

    Wang, Yanfang

    southern med univ

  • Y

    Yang, Yang

    southern med univ

  • L

    Liu, Hongmei (通讯)

    2 · southern med univ

  • H

    Huang, Wenhua (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417